Transcription factor RELB is a member of the NF-κB family, which has been utilized not only as a promising diagnostic and monitoring biomarker in renal fibrosis but has also been attributed to promote inflammatory cytokines expression to drive disease progression [45,46]. The gene discussed is NFKB1; the disease is renal fibrosis.